PharmaVision

PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare and investment community; performs due diligence research and provides expert commentary in healthcare. Reports combine expert opinion, scientific analysis, with market modeling to forecast delivery technologies, drugs and their potential revenue stream, key drivers and market trends.
 PharmaVision
 

List of reports from PharmaVision

Novel Antibodies & Therapeutic Proteins: Technology Challenges & Future Prospects
8/1/2010 | published by: PharmaVision
... & leading technologies driving the field; evaluate the unmet clinical needs, product pipelines & technological challenges for the next generation of mAbs & TPs; identify the key regulatory, IP & reimbursement issues which face biopharmaceutical ...  |  read more...
$1,566.00
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities
7/1/2009 | published by: PharmaVision
... the key therapeutic areas: cancer, CNS disorders, viral infectious diseases, ocular diseases, cardiovascular, metabolic and other conditions; identify key pharma & delivery specialists advancing RNAi-based therapeutics & diagnostics; gain an in-depth understanding of the technological ...  |  read more...
$1,566.00
Delivering New Biopharmaceutical Therapies: Challenges & Opportunities
1/19/2009 | published by: PharmaVision
... Sidney Taurel, Chairman and Chief Executive Officer Eli Lilly and Company A biopharmaceutical is defined as a medical drug (proteins including antibodies, nucleic acids, DNA, RNA or antisense oligonucleotides) which is produced using biotechnology. In ...  |  read more...
$1,415.00
Stem Cell-Based Therapeutic Delivery: Challenges & Opportunities
12/15/2008 | published by: PharmaVision
... all of the key therapeutic areas: autoimmune diseases, cardiovascular, CNS & hematological malignancies; identify key pharma & delivery specialists advancing the next generation of regenerative medicines; gain an in-depth understanding of the technological manufacturing & ...  |  read more...
$1,415.00
Drug Delivery Technology: Revolutionizing CNS Therapies
12/13/2007 | published by: PharmaVision
... infection, pain (both acute and chronic); chronic organic conditions such as neoplasms, seizure disorders; chronic degenerative disorders such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and other dementias, as well as the range of functional ...  |  read more...
$1,270.00
Drug Delivery Technology: Developing a New Generation of Vaccines
11/22/2007 | published by: PharmaVision
... vaccines for a wider range of diseases than was previously possible. The market looks set to explode over the next 5-10 years as a raft of new products based on these new technologies are developed ...  |  read more...
$1,270.00
Drug Delivery Technology: Revolutionizing Diabetes Treatment
9/20/2007 | published by: PharmaVision
... only route of administration was via subcutaneous injection. Whilst there have been marginal improvements in injectable devices - insulin “pens” - the recent approval of inhalable insulin is the first step to opening new opportunities ...  |  read more...
$1,270.00
Drug Delivery Technologies Revolutionizing Cancer Therapies
4/27/2007 | published by: PharmaVision
... and opportunities to increase the therapeutic index and ultimately deliver targeted therapies to cancer cells whilst minimizing off-target side effects.” Dr Cheryl Barton. The burden of disease cancer puts on society is huge. In 2000 ...  |  read more...
$1,270.00
Drug Delivery Technologies Revolutionizing Cardiovascular Therapies
4/7/2007 | published by: PharmaVision
... target specific areas of the vasculature. These advances will help to develop a new generation of medicines and devices to tackle the world’s leading killer.” Dr Cheryl Barton Cardiovascular disease (CVD) is the leading cause ...  |  read more...
$1,270.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!